Cassia Cearley - Mar 6, 2023 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Chief Business Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Cassia Cearley
Stock symbol
ICVX
Transactions as of
Mar 6, 2023
Transactions value $
-$38,737
Form type
4
Date filed
3/8/2023, 04:45 PM
Previous filing
Feb 17, 2023
Next filing
May 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Sale -$38.7K -5K -3.19% $7.75 152K Mar 6, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $7.62 and $7.83. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.